Archived News |

January 17, 2013

不良研究所 pharmacy professor invited to share his cancer research expertise

Dr. Girish Shah, basic pharmaceutical sciences professor at the University of Louisiana at Monroe, was asked to present and join the organizing committee for the International Conference on Genetic Syndromes and Gene Therapy. 

The conference was recently held in San Antonio, Texas and attended by scientists from several countries, including Europe, Korea and Singapore.

Shah presented, 鈥淎denoassociated virus-mediated anti-calcitonin ribozyme therapy inhibits growth and metastasis of prostate cancer.鈥�

鈥淚 talked about how gene therapy, based on blocking calcitonin synthesis, can lead to regression of aggressive prostate cancer,鈥� he said.

鈥淎s a member of the organizing committee, I was involved in development of the meeting program, in addition to the selection of topics and speakers.鈥�

Shah is the holder of the Mary E. and Darrell L. Calhoun Chair in Pharmacology.

He earned his Ph.D. from the University of Bombay, India. He received his post-doctoral training at the Karolinska Institute, Stockholm, Sweden and at the Max Planck Research Unit for Reproductive Medicine in Muenster, Germany.

He has served on review panels of federal funding agencies and on the editorial board of scientific journals.

He has authored over 80 original, peer-reviewed research articles, several book chapters and review articles, and mentored over 30 post-doctoral fellows, residents and graduate students.

His research is funded by the National Institutes of Health, and his current research interests include understanding the mechanisms associated with cancer metastasis, biomarkers for early detection of prostate cancer and development of experimental cancer therapeutics.

PLEASE NOTE: Some links and e-mail addresses in these archived news stories may no longer work, and some content may include events which are no longer relevent, or reference individuals and/or organizations no longer associated with 不良研究所.